ea0035p865 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014
Galdiero Mariano
, Auriemma Renata S
, Vitale Pasquale
, Calzo Fabio Lo
, Salzano Ciro
, Ferreri Lucia
, Cariati Federica
, Coppola Giorgio
, Colao Annamaria
, Pivonello Rosario
Generously supported by IPSEN)-->Hyperprolactinemia is reportedly associated with impaired metabolic profile, particularly in patients with concomitant hypogonadism. The current study aimed at investigating the effects of 12 and 24 month-continuous cabergoline (CAB) treatment on metabolic profile in male hyperprolactinemic patients. Thirty-two men with prolactinomas, including 22 with testosterone < 8 nmol/l (HG, 69%) and 10 with...